Misinterpretation of prolactin levels leading to management errors in patients with sellar enlargement
- 1 January 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 82 (1), 29-32
- https://doi.org/10.1016/0002-9343(87)90373-1
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- THE EFFECT OF DOPAMINE AGONIST THERAPY ON LARGE FUNCTIONLESS PITUITARY TUMOURSClinical Endocrinology, 1985
- Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumorsJournal of Neurosurgery, 1984
- Pituitary adenomas: Immunohistology and ultrastructural analysis of 118 tumorsActa Neuropathologica, 1983
- Bromocriptine in management of large pituitary tumours.BMJ, 1982
- Size Reduction of Macroprolactinomas by Bromocriptine or Lisuride Treatment*Journal of Clinical Endocrinology & Metabolism, 1981
- Serum prolactin in patients with hypothalamus and pituitary disordersJournal of Neurosurgery, 1981
- PREVALENCE AND PRESENTATION OF HYPERPROLACTINÆMIA IN PATIENTS WITH "FUNCTIONLESS" PITUITARY TUMOURSThe Lancet, 1977